Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Martindale corrects stated sucrose content in methadone

Martindale Pharmaceuticals has announced corrections to errors in the amount of sucrose stated in two of its methadone products.

The incorrect information was given for the total sucrose content and daily maximum dose, which was stated on methadone oral solution 1mg/ml and methadone mixture 1mg/ml.

The accurate data of both products is 441.5mg/ml total sucrose content and 26.49g daily maximum dose.

The methadone had incorrectly stated these quantities as 197.17mg/ml and 11.83g respectively.

Martindale said: “We sincerely apologise for any inconvenience caused by this misinformation.”

It had submitted a “variation to amend this error”, in the summary of product characteristics (SmPC) and the patient information leaflet (PIL), to the Medicines & Healthcare Products Regulatory Agency (MHRA), it added.

The current SmPC and PIL for these products “have now been updated with the correct quantity of sucrose”, it said.

Product name
Product license number
Incorrect total sucrose content; Daily maximum dose
Correct total sucrose content; Daily maximum dose
Methadone Oral Solution 1mg/ml
PL 00156/0340
197.17mg/ml; 11.83g
441.5mg/ml; 26.49 g
Methadone Mixture 1mg/ml, drug tariff formula (DTF), physeptone mixture
PL 01883/0018
197.17mg/ml; 11.83g
441.5mg/ml: 26.49 g

Do you have any methadone with the incorrect sugar content stated?

Related Content

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD008793

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel